Literature DB >> 1689749

The T cell repertoire to a multideterminant antigen. Clonal heterogeneity of the T cell response, variation between syngeneic individuals, and in vitro selection of T cell specificities.

G Gammon1, J Klotz, D Ando, E E Sercarz.   

Abstract

The specificity of lysozyme-induced T cell proliferative responses by individual B10.A mice was compared by using a panel of three peptides. A surprising degree of variation in the focus of the responses was observed among individual animals, both in the newly isolated lymph node cell populations and in long term T cell lines. The responses to each determinant after hen egg-white lysozyme immunization were not equal and in examining the mice as a group some determinants tended to be dominant. However, despite each animal favoring a restricted number of determinants, the responding T cell populations were still highly heterogeneous. The data suggest that many determinants are involved in the response to the whole Ag. The role of one or more dominant determinants can be overestimated because the degree of heterogeneity in long term T cell lines appears to be less than in freshly obtained lymph node cells, indicating that a process of in vitro selection occurs. We observed that the T cells responsive to one peptide, 46-61, appeared to have a selective advantage in vitro culture.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689749

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Induction of a pharmacologically active clonotypic B cell response directed to an immunogenic region of the human beta 2-adrenergic receptor.

Authors:  J G Guillet; R Lengagne; Y Magnusson; K Tate; A D Strosberg; J Hoebeke
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  Fine mapping of T-cell determinants of bovine beta-lactoglobulin.

Authors:  M Totsuka; A Ametani; S Kaminogawa
Journal:  Cytotechnology       Date:  1997       Impact factor: 2.058

3.  Peripheral CD25 positive T lymphocytes with biased T cell receptor Vbeta gene usage in autoimmune endogenous posterior uveitis.

Authors:  P J Tighe; J V Forrester; J Liversidge; H F Sewell
Journal:  Clin Mol Pathol       Date:  1995-02

4.  Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein.

Authors:  M W Cunningham; S M Antone; M Smart; R Liu; S Kosanke
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

5.  Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope.

Authors:  T H Thatcher; D P O'Brien; S Altuwaijri; R K Barth
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

6.  Intragraft selection of the T cell receptor repertoire by class I MHC sequences in tolerant recipients.

Authors:  Dahai Liu; Xiu-Da Shen; Yuan Zhai; Wengsi Lam; Jingying Liao; Ronald W Busuttil; Rafik M Ghobrial
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

7.  Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.

Authors:  M Shirai; T Akatsuka; C D Pendleton; R Houghten; C Wychowski; K Mihalik; S Feinstone; J A Berzofsky
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Maturation of the antibody response to a protein-coupled form of the organophosphorus toxin soman.

Authors:  A C Buenafe; M B Rittenberg
Journal:  Immunology       Date:  1991-08       Impact factor: 7.397

9.  In vitro responses of cheetah mononuclear cells to feline herpesvirus-1 and Cryptococcus neoformans.

Authors:  M A Miller-Edge; M B Worley
Journal:  Vet Immunol Immunopathol       Date:  1992-01-15       Impact factor: 2.046

10.  Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.

Authors:  Lisa Bruns; Oliver Frey; Lars Morawietz; Christiane Landgraf; Rudolf Volkmer; Thomas Kamradt
Journal:  Arthritis Res Ther       Date:  2009-07-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.